Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 410

1.
2.
3.
4.
7.

Regulation of ion channels in myocardial cells and protection of ischemic myocardium.

Sperelakis N, Sunagawa M, Yokoshiki H, Seki T, Nakamura M.

Heart Fail Rev. 2000 Jun;5(2):139-66. Review. No abstract available.

PMID:
16228141
8.

Boundary effects influence velocity of transverse propagation of simulated cardiac action potentials.

Sperelakis N, Kalloor B, Ramasamy L.

Theor Biol Med Model. 2005 Sep 6;2:36.

9.

Propagated repolarization of simulated action potentials in cardiac muscle and smooth muscle.

Sperelakis N, Ramasamy L, Kalloor B.

Theor Biol Med Model. 2005 Feb 14;2:5.

10.

Gap-junction channels inhibit transverse propagation in cardiac muscle.

Sperelakis N, Ramasamy L.

Biomed Eng Online. 2005 Jan 28;4:7.

13.

Activation of intestinal smooth muscle cells by interstitial cells of Cajal in simulation studies.

Sperelakis N, Daniel EE.

Am J Physiol Gastrointest Liver Physiol. 2004 Feb;286(2):G234-43.

15.

Vasodilating mechanisms of levosimendan.

Yokoshiki H, Sperelakis N.

Cardiovasc Drugs Ther. 2003 Mar;17(2):111-3. No abstract available.

PMID:
14562823
16.
17.

Modeling electric field transfer of excitation at cell junctions.

Sperelakis N, Ramasamy L.

IEEE Eng Med Biol Mag. 2002 Nov-Dec;21(6):130-43. No abstract available.

PMID:
12613222
18.

An electric field mechanism for transmission of excitation between myocardial cells.

Sperelakis N.

Circ Res. 2002 Nov 29;91(11):985-7. No abstract available.

PMID:
12456483
19.

Electric field interactions between closely abutting excitable cells. .

Sperelakis N, McConnell K.

IEEE Eng Med Biol Mag. 2002 Jan-Feb;21(1):77-89. Review. No abstract available.

PMID:
11935993
20.

Levosimendan increases L-type Ca(2+) current via phosphodiesterase-3 inhibition in human cardiac myocytes.

Ajiro Y, Hagiwara N, Katsube Y, Sperelakis N, Kasanuki H.

Eur J Pharmacol. 2002 Jan 18;435(1):27-33.

PMID:
11790375
21.

Lack of tyrosine protein kinase regulation of L-type Ca2+ channel current in transfected cells stably expressing alpha1C-b Subunit.

Sunagawa M, Nakamura M, Kosugi T, Hofmann F, Sperelakis N.

Jpn J Physiol. 2001 Feb;51(1):115-9.

PMID:
11282003
22.

Inhibition of Ca2+-activated K+ channels by tyrosine phosphatase inhibitors in rat mesenteric artery.

Yokoshiki H, Seki T, Sunagawa M, Sperelakis N.

Can J Physiol Pharmacol. 2000 Sep;78(9):745-50.

PMID:
11007538
23.

Actin filament disruption inhibits L-type Ca(2+) channel current in cultured vascular smooth muscle cells.

Nakamura M, Sunagawa M, Kosugi T, Sperelakis N.

Am J Physiol Cell Physiol. 2000 Aug;279(2):C480-7.

24.

Role of voltage-dependent and Ca(2+)-activated K(+) channels on the regulation of isometric force in porcine coronary artery.

Shimizu S, Yokoshiki H, Sperelakis N, Paul RJ.

J Vasc Res. 2000 Jan-Feb;37(1):16-25.

PMID:
10720882
25.

Direct block of Ca2+ channels by calmidazolium in cultured vascular smooth muscle cells.

Sunagawa M, Yokoshiki H, Seki T, Nakamura M, Laber P, Sperelakis N.

J Cardiovasc Pharmacol. 1999 Oct;34(4):488-96.

PMID:
10511122
26.

Evidence for presence of ATP-sensitive K+ channels in rat colonic smooth muscle cells.

Plujà L, Yokoshiki H, Sperelakis N.

Can J Physiol Pharmacol. 1998 Dec;76(12):1166-70.

PMID:
10326841
27.

L-type Ca2+ currents in ventricular myocytes from neonatal and adult rats.

Katsube Y, Yokoshiki H, Nguyen L, Yamamoto M, Sperelakis N.

Can J Physiol Pharmacol. 1998 Sep;76(9):873-81.

PMID:
10066137
28.
29.

Angiotensin II stimulation of Ca2+-channel current in vascular smooth muscle cells is inhibited by lavendustin-A and LY-294002.

Seki T, Yokoshiki H, Sunagawa M, Nakamura M, Sperelakis N.

Pflugers Arch. 1999 Feb;437(3):317-23.

PMID:
9914387
30.

Carbachol inhibition of Ca2+ currents in ventricular cells obtained from neonatal and adult rats.

Katsube Y, Yokoshiki H, Sunagawa M, Seki T, Yamamoto M, Sperelakis N.

Eur J Pharmacol. 1998 Oct 9;358(3):269-75.

PMID:
9822894
31.
32.

Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes.

Matlib MA, Zhou Z, Knight S, Ahmed S, Choi KM, Krause-Bauer J, Phillips R, Altschuld R, Katsube Y, Sperelakis N, Bers DM.

J Biol Chem. 1998 Apr 24;273(17):10223-31.

33.

Inhibition of Ca2+ current in neonatal and adult rat ventricular myocytes by the tyrosine kinase inhibitor, genistein.

Katsube Y, Yokoshiki H, Nguyen L, Yamamoto M, Sperelakis N.

Eur J Pharmacol. 1998 Mar 26;345(3):309-14.

PMID:
9592031
34.
35.

Review of some actions of taurine on ion channels of cardiac muscle cells and others.

Satoh H, Sperelakis N.

Gen Pharmacol. 1998 Apr;30(4):451-63. Review.

PMID:
9522160
36.

ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.

Yokoshiki H, Sunagawa M, Seki T, Sperelakis N.

Am J Physiol. 1998 Jan;274(1):C25-37. doi: 10.1152/ajpcell.1998.274.1.C25. Review.

PMID:
9458709
37.
38.
39.

The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells.

Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N.

J Pharmacol Exp Ther. 1997 Oct;283(1):375-83.

PMID:
9336346
40.

Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes.

Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N.

Eur J Pharmacol. 1997 Aug 27;333(2-3):249-59.

PMID:
9314042
41.

Disruption of actin cytoskeleton attenuates sulfonylurea inhibition of cardiac ATP-sensitive K+ channels.

Yokoshiki H, Katsube Y, Sunugawa M, Seki T, Sperelakis N.

Pflugers Arch. 1997 Jun;434(2):203-5.

PMID:
9136675
42.

Cyclic nucleotides regulate the activity of L-type calcium channels in smooth muscle cells from rat portal vein.

Liu H, Xiong Z, Sperelakis N.

J Mol Cell Cardiol. 1997 May;29(5):1411-21.

PMID:
9201626
43.

Regulation of Ca2+ channel currents by intracellular ATP in smooth muscle cells of rat mesenteric artery.

Yokoshiki H, Katsube Y, Sperelakis N.

Am J Physiol. 1997 Feb;272(2 Pt 2):H814-9.

PMID:
9124443
44.

Cyclic GMP-dependent protein kinase regulates the L-type calcium current in rat ventricular myocytes.

Sumii K, Imazu M, Yamakido M, Sperelakis N.

Heart Vessels. 1997;Suppl 12:62-5.

PMID:
9476546
45.

Differences in isoproterenol stimulation of Ca2+ current of rat ventricular myocytes in neonatal compared to adult.

Katsube Y, Yokoshiki H, Nguyen L, Sperelakis N.

Eur J Pharmacol. 1996 Dec 19;317(2-3):391-400.

PMID:
8997626
46.

Na+/Ca2+ exchange current: lack of effect of taurine.

Katsube Y, Sperelakis N.

Eur J Pharmacol. 1996 Nov 28;316(1):97-103.

PMID:
8982656
47.

Regulation of the slow Ca++ channels of myocardial cells.

Sperelakis N, Katsube Y, Yokoshiki H, Sada H, Sumii K.

Mol Cell Biochem. 1996 Oct-Nov;163-164:85-98. Review.

PMID:
8974043
48.

Amino acid substitutions in the rat Na+, K(+)-ATPase alpha 2-subunit alter the cation regulation of pump current expressed in HeLa cells.

Yamamoto S, Kuntzweiler TA, Wallick ET, Sperelakis N, Yatani A.

J Physiol. 1996 Sep 15;495 ( Pt 3):733-42.

49.

Kinetic mechanism of Na+ channel depression by taurine in guinea pig ventricular myocytes.

Sada H, Ban T, Sperelakis N.

Jpn J Pharmacol. 1996 Jun;71(2):147-59.

50.

Suppression of channel conductance by diacetyl monoxime in guinea pig and embryonic chick cardiomyocytes.

Sada H, Ban T, Sperelakis N.

Zhongguo Yao Li Xue Bao. 1996 May;17(3):201-6.

Supplemental Content

Loading ...
Support Center